AdaptHealth (AHCO) Revenue & Revenue Breakdown
AdaptHealth Revenue Highlights
Latest Revenue (Y)
$3.26B
Latest Revenue (Q)
$820.31M
Main Segment (Y)
Respiratory Health
Main Geography (Y)
Supplies To Home
AdaptHealth Revenue by Period
AdaptHealth Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $3.26B | 1.90% |
| 2023-12-31 | $3.20B | 7.73% |
| 2022-12-31 | $2.97B | 21.02% |
| 2021-12-31 | $2.45B | 132.35% |
| 2020-12-31 | $1.06B | 99.45% |
| 2019-12-31 | $529.64M | 53.40% |
| 2018-12-31 | $345.28M | 79.31% |
| 2017-12-31 | $192.56M | 10.47% |
| 2016-12-31 | $174.32M | - |
AdaptHealth generated $3.26B in revenue during NA 2024, up 1.90% compared to the previous quarter, and up 615.69% compared to the same period a year ago.
AdaptHealth Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $820.31M | 2.49% |
| 2025-06-30 | $800.37M | 37.88% |
| 2025-03-31 | $580.47M | -32.24% |
| 2024-12-31 | $856.64M | 6.30% |
| 2024-09-30 | $805.86M | -0.01% |
| 2024-06-30 | $805.98M | 1.70% |
| 2024-03-31 | $792.50M | -7.66% |
| 2023-12-31 | $858.23M | 6.74% |
| 2023-09-30 | $804.03M | 1.35% |
| 2023-06-30 | $793.29M | 6.53% |
| 2023-03-31 | $744.63M | -4.57% |
| 2022-12-31 | $780.28M | 39.92% |
| 2022-09-30 | $557.65M | -23.36% |
| 2022-06-30 | $727.61M | 3.03% |
| 2022-03-31 | $706.20M | 0.58% |
| 2021-12-31 | $702.11M | 7.47% |
| 2021-09-30 | $653.29M | 5.88% |
| 2021-06-30 | $617.02M | 27.98% |
| 2021-03-31 | $482.12M | 38.37% |
| 2020-12-31 | $348.43M | 22.51% |
| 2020-09-30 | $284.40M | 22.53% |
| 2020-06-30 | $232.12M | 21.25% |
| 2020-03-31 | $191.44M | 28.02% |
| 2019-12-31 | $149.54M | 9.59% |
| 2019-09-30 | $136.45M | 9.90% |
| 2019-06-30 | $124.15M | 3.90% |
| 2019-03-31 | $119.50M | 9.98% |
| 2018-12-31 | $108.65M | 6.36% |
| 2018-09-30 | $102.16M | 51.94% |
| 2018-06-30 | $67.23M | -0.00% |
| 2018-03-31 | $67.23M | - |
AdaptHealth generated $820.31M in revenue during Q3 2025, up 2.49% compared to the previous quarter, and up 101.78% compared to the same period a year ago.
AdaptHealth Revenue Breakdown
AdaptHealth Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|---|
| Respiratory Health | $651.15M | - | - | - |
| Health Care, Other | - | $301.15M | $261.62M | - |
| Diabetes | - | $660.04M | $687.09M | - |
| Supplies To Home | - | - | - | $145.62M |
AdaptHealth's latest annual revenue breakdown by segment (product or service), as of Dec 24: Respiratory Health (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|
| Respiratory Health | $177.00M | $170.45M | $165.48M | - | - | - | - | - | - |
| Health Care, Other | - | - | - | $74.55M | $67.23M | $92.17M | $77.09M | $68.13M | - |
| Supplies To Home | - | - | - | - | - | - | - | - | $45.15M |
AdaptHealth's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Respiratory Health (100.00%).
AdaptHealth Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| Supplies To Home | $145.62M |
AdaptHealth's latest annual revenue breakdown by geography, as of Dec 20: Supplies To Home (100.00%).
Quarterly Revenue by Country
| Country | Dec 20 |
|---|---|
| Supplies To Home | $45.15M |
AdaptHealth's latest quarterly revenue breakdown by geography, as of Dec 20: Supplies To Home (100.00%).
AdaptHealth Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AHCO | AdaptHealth | $3.26B | $820.31M |
| HCSG | Healthcare Services Group | $1.72B | $464.34M |
| CNMD | CONMED | $1.31B | $337.93M |
| AMPH | Amphastar Pharmaceuticals | $712.81M | $191.84M |
| UFPT | UFP | $504.42M | $154.56M |
| INMD | InMode | $492.05M | $80.28M |
| ESTA | Establishment Labs | $166.03M | $53.78M |
| IRMD | IRadimed | $73.24M | $21.20M |
| BBNX | Beta Bionics | $65.12M | $27.25M |
| CVAC | CureVac | $52.70M | $12.37M |
| STAA | STAAR Surgical | $313.90K | $44.32B |